Compare ONDS & MIR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | ONDS | MIR |
|---|---|---|
| Founded | 2014 | 2005 |
| Country | United States | United States |
| Employees | N/A | 3281 |
| Industry | Telecommunications Equipment | Industrial Machinery/Components |
| Sector | Telecommunications | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 4.8B | 4.6B |
| IPO Year | 2015 | N/A |
| Metric | ONDS | MIR |
|---|---|---|
| Price | $8.80 | $17.72 |
| Analyst Decision | Strong Buy | Strong Buy |
| Analyst Count | 6 | 8 |
| Target Price | $19.83 | ★ $27.25 |
| AVG Volume (30 Days) | ★ 82.8M | 3.2M |
| Earning Date | 03-23-2026 | 04-28-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 30.68 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $7,192,694.00 | N/A |
| Revenue This Year | $256.57 | $24.16 |
| Revenue Next Year | $77.10 | $7.31 |
| P/E Ratio | ★ N/A | $195.00 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $0.66 | $12.00 |
| 52 Week High | $15.28 | $30.28 |
| Indicator | ONDS | MIR |
|---|---|---|
| Relative Strength Index (RSI) | 38.76 | 33.69 |
| Support Level | $6.20 | N/A |
| Resistance Level | $11.87 | $22.23 |
| Average True Range (ATR) | 0.89 | 1.04 |
| MACD | -0.13 | -0.07 |
| Stochastic Oscillator | 2.00 | 4.05 |
Ondas Holdings Inc designs, develops, manufactures, sells, and supports FullMAX Software Defined Radio (SDR) technology in the United States, Israel, and India. The company operates in two business segments namely Ondas Networks and Ondas Autonomous Systems. The company generates maximum revenue from Ondas Autonomous Systems through the sales of the Optimus system and separately priced support, maintenance, and ancillary services related to the sale of the Optimus system.
Mirion Technologies Inc provides products, services, and software that allow customers to safely leverage the power of ionizing radiation for applications that benefit the health, safety, vitality, and technological progress of the human experience. The Company manages its operations through two segments: Nuclear & Safety and Medical. The Medical segment improves the quality and safety of cancer care delivery and supports applications across medical diagnostics and practitioner safety. The Nuclear & Safety segment powers advancements in nuclear energy and critical radiation safety, measurement and analysis applications across laboratories, research and other industrial markets such as defense.